Financial AnaysisBy Glenn De Koeijer2FV01

Overview• Introduction• Stock price analysis• Result per share analysis• Revenue & income statement• Prediction income statement• Conclusion• Sources

Introduction• Leuven (Belgium)• New Jersey (U.S.)• Dublin (Ireland)

• +/- 130employees

• Ophthalmic medicines

Stock price graphic (1year)

Stock price graphic since 31/12/2007

Result per share

Revenu & income statement

Prediction income statement

Conclusion

• Signs of great future • Annual results not good• Stock price climbed• 2012 peak• Future ensured

Sources• http://

www.euroinvestor.com/exchanges/euronext-brussels/thrombogenics/580079

• http://nl.wikipedia.org/wiki/ThromboGenics• http://thrombogenics.com/company-overview/• http://

thrombogenics.com/wp-content/uploads/2011/03/TG-AR2011-EN_financial4.pdf

• http://www.slideshare.net/Lien2AF3/financial-analysis-of-the-cocacola-company

• http://www.tijd.be/beurzen/ThromboGenics.60191463• http://

markets.ft.com/research/Markets/Tearsheets/Financials?s=THR:BRU• http://www.4-traders.com/THROMBOGENICS-29715/financials/

Thank you for watchingAny questions glendkoe@student.arteveldehs.be